10/29/2025
Reach out for more details and to see if you or a loved one may qualify!
☎️ (402) 282-1502
📧 contact@pcresearch.health
📣MARITIME-CV is a Phase 3 study for people living with a cardiovascular condition and overweight or obesity. In this study, we are exploring if an investigational medicine (a monthly injection) is safe to use, and whether it can reduce the risk of cardiovascular events, such as heart attacks and stroke in people with cardiovascular conditions.
More details in the link below. ⬇️
The MARITIME-1 study examines obesity and other weight-related conditions such as hypertension or dyslipidemia, investigating a monthly injection